Digistain LIMITED
Digistain is a company that has developed an MHRA-cleared technology for breast cancer biomarker analytics. Their solution aims to reduce the time and cost associated with traditional methods, providing insights into the likelihood of cancer recurrence.
- Digistain Prognostic Score
- AI-enabled biomarker analytics
- Breast cancer recurrence risk profiling